Pharmacoeconomic evaluation of first-line combination therapy with immunotherapy drugs and platinum-containing chemotherapy in adult patients with metastatic non-squamous non-small cell lung cancer
Objective: to evaluate the pharmacoeconomic efficacy of "atezolizumab + bevacizumab + paclitaxel + carboplatin" drug combination compared to "pembrolizumab + pemetrexed + carboplatin" combination in adult patients with non-small cell lung cancer (NSCLC) in the first line of thera...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Kirja |
| Julkaistu: |
IRBIS LLC,
2024-05-01T00:00:00Z.
|
| Aiheet: | |
| Linkit: | Connect to this object online. |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|
Internet
Connect to this object online.3rd Floor Main Library
| Hyllypaikka: |
A1234.567 |
|---|---|
| Nide 1 | Saatavissa |